These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37506990)

  • 21. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
    Mediratta A; Addetia K; Yamat M; Moss JD; Nayak HM; Burke MC; Weinert L; Maffessanti F; Jeevanandam V; Mor-Avi V; Lang RM
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):337-47. PubMed ID: 24631508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pacemaker following transcatheter aortic valve replacement and tricuspid regurgitation: A single-center experience.
    Nona P; Coriasso N; Khan A; Singh G; Eng MH; Frisoli T; O'Neill BP; Villablanca PA; Lee JC; Jacobsen G; O'Neill WW; Wang DD
    J Card Surg; 2022 Sep; 37(9):2937-2942. PubMed ID: 33533038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation.
    Park SJ; Gentry JL; Varma N; Wazni O; Tarakji KG; Mehta A; Mick S; Grimm R; Wilkoff BL
    JACC Clin Electrophysiol; 2018 Nov; 4(11):1421-1428. PubMed ID: 30466846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation.
    Riesenhuber M; Spannbauer A; Gwechenberger M; Pezawas T; Schukro C; Stix G; Schneider M; Goliasch G; Anvari A; Wrba T; Khazen C; Andreas M; Laufer G; Hengstenberg C; Gyongyosi M
    Clin Res Cardiol; 2021 Jun; 110(6):884-894. PubMed ID: 33566185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of tricuspid valve regurgitation following laser lead extraction†.
    Pecha S; Castro L; Gosau N; Linder M; Vogler J; Willems S; Reichenspurner H; Hakmi S
    Eur J Cardiothorac Surg; 2017 Jun; 51(6):1108-1111. PubMed ID: 28204134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term effects of permanent pacemaker implantation on tricuspid valve regurgitation].
    Ren CL; Wang Y; Wang R; Li BJ; Geng RY; Gao CQ
    Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(30):2118-22. PubMed ID: 23158275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.
    Schewel D; Schewel J; Schlüter M; Kreidel F; Schmidt T; Schmoeckel M; Elsässer A; Kuck KH; Frerker C
    Int J Cardiol; 2018 Jun; 261():37-41. PubMed ID: 29572082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.
    Wiechecka K; Wiechecki B; Kapłon-Cieślicka A; Tymińska A; Budnik M; Hołowaty D; Jakubowski K; Michalak M; Świętoń E; Stolarz P; Steckiewicz R; Grabowski M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Cardiol J; 2020; 27(6):797-806. PubMed ID: 31225634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of tricuspid regurgitation and right ventricular dysfunction on long-term mortality in patients undergoing cardiac devices implantation: >10-year follow-up study.
    Papageorgiou N; Falconer D; Wyeth N; Lloyd G; Pellerin D; Speechly-Dick E; Segal OR; Lowe M; Rowland E; Lambiase PD; Chow AW; Bhattacharyya S
    Int J Cardiol; 2020 Nov; 319():52-56. PubMed ID: 32470533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H; Seo Y; Ishizu T; Iida N; Sato K; Yamamoto M; Machino-Ohtsuka T; Nogami A; Ohte N; Ieda M
    Circ J; 2020 Nov; 84(12):2302-2311. PubMed ID: 33071243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation.
    Seo J; Kim DY; Cho I; Hong GR; Ha JW; Shim CY
    PLoS One; 2020; 15(6):e0235230. PubMed ID: 32589674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting predictors of worse atrioventricular valve and left ventricular systolic function following pacemaker therapy.
    Sasaki K; Togashi D; Nakajima I; Nakayama Y; Harada T; Akashi YJ
    Pacing Clin Electrophysiol; 2023 Dec; 46(12):1643-1651. PubMed ID: 37904603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
    Bertrand PB; Overbey JR; Zeng X; Levine RA; Ailawadi G; Acker MA; Smith PK; Thourani VH; Bagiella E; Miller MA; Gupta L; Mack MJ; Gillinov AM; Giustino G; Moskowitz AJ; Gelijns AC; Bowdish ME; O'Gara PT; Gammie JS; Hung J;
    J Am Coll Cardiol; 2021 Feb; 77(6):713-724. PubMed ID: 33573741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
    Cheng Y; Gao H; Tang L; Li J; Yao L
    Echocardiography; 2016 Nov; 33(11):1689-1696. PubMed ID: 27539645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation.
    Van De Heyning CM; Elbarasi E; Masiero S; Brambatti M; Ghazal S; Al-Maashani S; Capucci A; Leong D; Shivalkar B; Saenen JB; Miljoen HP; Morillo CA; Divarakarmenon S; Amit G; Ribas S; Baiocco E; Maolo A; Romandini A; Maffei S; Connolly SJ; Healey JS; Dokainish H
    Can J Cardiol; 2019 Apr; 35(4):389-395. PubMed ID: 30852048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pacemaker-induced tricuspid regurgitation is uncommon immediately post-implantation.
    Rothschild DP; Goldstein JA; Kerner N; Abbas AE; Patel M; Wong WS
    J Interv Card Electrophysiol; 2017 Sep; 49(3):281-287. PubMed ID: 28685199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads.
    Trankle CR; Gertz ZM; Koneru JN; Kasirajan V; Nicolato P; Bhardwaj HL; Ellenbogen KA; Kalahasty G
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):845-853. PubMed ID: 29757467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing.
    Alizadeh A; Sanati HR; Haji-Karimi M; Yazdi AH; Rad MA; Haghjoo M; Emkanjoo Z
    Europace; 2011 Nov; 13(11):1587-90. PubMed ID: 21742681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tricuspid valve malfunction and ventricular pacemaker lead: case report and review of the literature.
    Iskandar SB; Ann Jackson S; Fahrig S; Mechleb BK; Garcia ID
    Echocardiography; 2006 Sep; 23(8):692-7. PubMed ID: 16970722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
    Murphy SP; Lew J; Yucel E; Singh J; Mela T
    J Cardiovasc Electrophysiol; 2024 May; 35(5):1017-1025. PubMed ID: 38501386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.